BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Basilea Pharmaceutica 

Grenzacherstrasse 487

Basel    CH-4005  Switzerland
Phone: 41-61-6061-111 Fax: 41-61-6061-112


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
Resolutions Of The Ordinary General Meeting Of Shareholders Of Basilea Pharmaceutica (BSLN.SW) 4/10/2014 8:00:27 AM    More...
Basilea Pharmaceutica (BSLN.SW)'s Oncology Drug Candidate BAL101553 Demonstrates Broad Antitumor Activity In Treatment-Resistant Breast Cancer Models As Presented At American Association for Cancer Research 4/7/2014 8:43:06 AM    More...
Basilea Pharmaceutica (BSLN.SW) Swaps Its Isavuconazole North American Co-Promote Rights For Full Isavuconazole Rights Outside Of North America 2/28/2014 9:44:35 AM    More...
Basilea Pharmaceutica (BSLN.SW) Reports That Isavuconazole Receives Qualified Infectious Disease Product Designation From FDA For The Treatment Of Invasive Mucormycosis 2/27/2014 9:28:26 AM    More...
Basilea Pharmaceutica (BSLN.SW) 2013 Full-Year Results: Strong Operational And Financial Performance 2/11/2014 9:23:41 AM    More...
Basilea Pharmaceutica (BSLN.SW) Reports That Isavuconazole Receives Qualified Infectious Disease Product (QIDP) Designation From U.S. FDA For The Treatment Of Invasive Aspergillosis 12/3/2013 9:34:05 AM    More...
Basilea Pharmaceutica (BSLN.SW) Reports Isavuconazole Orphan Drug Designation For Treatment Of Zygomycosis By FDA 11/18/2013 9:17:04 AM    More...
Basilea Pharmaceutica (BSLN.SW) Appoints New Chief Financial Officer 11/4/2013 9:37:27 AM    More...
Basilea Pharmaceutica (BSLN.SW): Antibiotic Ceftobiprole Obtains Regulatory Approval in Europe for Pneumonia 10/23/2013 8:29:03 AM    More...
Swissmedic Accepts for Review Basilea Pharmaceutica (BSLN.SW)'s Ceftobiprole Marketing Authorization Application for the Treatment of Pneumonia 9/16/2013 9:33:00 AM    More...
12345678910...